Overview of the APLT Lawsuit
Levi & Korsinsky, LLP is notifying shareholders of Applied Therapeutics, Inc. about a significant class action securities lawsuit concerning investor rights. This legal action arises from alleged securities fraud that occurred over a specific period, impacting many investors who trusted the Company.
What Led to the Lawsuit?
The lawsuit focuses on the time frame of January 3, 2024, to December 2, 2024, during which various adverse claims about the company’s conduct emerged. The allegations indicate that investors might have faced severe financial losses due to misleading information disseminated by Applied Therapeutics prior to major announcements.
Key Events Impacting Share Prices
One of the most critical moments for Applied Therapeutics occurred on November 27, 2024, when the company announced it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application for govorestat. This notification indicated that the FDA could not approve the proposed drug due to identified deficiencies in the application process, leading to a drastic fall in the company’s stock price.
Stock Price Decline
Following the CRL announcement, Applied Therapeutics witnessed a sharp decline in its stock price. It started at a closing market price of $10.21 per share and plummeted to $8.57 the next day. The downward trend continued, ultimately reaching prices as low as $1.75 per share by December 2, 2024. This represented a staggering decline of over 80%, signaling distress among investors.
The Future for APLT Investors
If you are an investor affected by these developments, you still have opportunities to assert your rights. A critical date to remember is February 18, 2025, which is your deadline to request that the Court appoint you as the lead plaintiff in this lawsuit. However, it's important to know that participating in any recovery does not require you to take on this role.
Cost-Free Participation
One reassuring aspect for investors is that joining this class action does not incur any costs. If you are eligible, you may be entitled to compensation without needing to pay out of pocket. This openness is crucial as it allows more investors to make informed decisions without the burden of financial risk.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has built a notable reputation over the past two decades. The firm has successfully secured hundreds of millions for shareholders and has a track record of winning complex securities litigation cases. With a dedicated team of over 70 professionals, they are well-equipped to represent investors in this challenging legal landscape.
Contact Information for Assistance
If you are seeking assistance or have questions regarding your participation in the class action, you can reach out to Joseph E. Levi, Esq. at (212) 363-7500. Their office is located at 33 Whitehall Street, 17th Floor, New York, NY 10004.
Frequently Asked Questions
What should I do if I'm affected by the APLT lawsuit?
If you believe you've suffered losses due to the alleged fraud, you should consider joining the lawsuit before the February 18, 2025 deadline.
How can I participate in the class action?
You can contact Levi & Korsinsky for guidance on how to join the class action and understand your rights as an investor.
What costs are involved in joining the class action?
There are no out-of-pocket costs for class members to participate in the lawsuit.
Why is Levi & Korsinsky recommended for this case?
Levi & Korsinsky has extensive experience in securities litigation and a strong history of success, which can provide confidence to investors.
How will the lawsuit affect the company going forward?
The lawsuit may significantly impact Applied Therapeutics’ reputation and its ability to raise funds, which could influence its market performance.
